Results 151 to 160 of about 19,663,059 (423)

A Tri-Mode Coupled Coil with Tunable Focal Point Adjustment for Bio-Medical Applications [PDF]

open access: yesarXiv, 2018
The paper proposes the design of a tri-mode coupled coil which enables three modes of operation for inducing electromagnetic field, where the focal adjustment of the E field can be optimized. Methods: The setup consists of two identical figure-of-eight coils, namely coil 1 and coil 2, coupled to each other by magnetic resonance coupling.
arxiv  

A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini   +11 more
wiley   +1 more source

Optimal Value of Current Ratio [PDF]

open access: yesHradec Economic Days, 2020
Michal Kuběnka, Irena Honková
openaire   +1 more source

Improved approximation ratios for two Euclidean maximum spanning tree problems [PDF]

open access: yesarXiv, 2020
We study the following two maximization problems related to spanning trees in the Euclidean plane. It is not known whether or not these problems are NP-hard. We present approximation algorithms with better approximation ratios for both problems. The improved ratios are obtained mainly by employing the Steiner ratio, which has not been used in this ...
arxiv  

Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors

open access: yesMolecular Oncology, EarlyView.
Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi   +6 more
wiley   +1 more source

On‐treatment dynamics of circulating extracellular vesicles in the first‐line setting of patients with advanced non‐small cell lung cancer: the LEXOVE prospective study

open access: yesMolecular Oncology, Volume 19, Issue 5, Page 1422-1435, May 2025.
The LEXOVE prospective study evaluated plasma cell‐free extracellular vesicle (cfEV) dynamics using Bradford assay and dynamic light scattering in metastatic non‐small cell lung cancer patients undergoing first‐line treatments, correlating a ∆cfEV < 20% with improved median progression‐free survival in responders versus non‐responders.
Valerio Gristina   +17 more
wiley   +1 more source

Pengaruh Ukuran Perusahaan, Current Ratio Dan Total Assets Turn Over Ratio Terhadap Ketepatan Perkiraan Laba Pada Perusahaan Yang IPO Di BEI [PDF]

open access: yes, 2013
This research basically discusses the effect of firm size, current ratio, and total assets turnover ratio of the accuracy of earnings estimates. The objectives of this research to prove that there is a significant effect of the three variables partially ...
., Novianti
core  

Solar neutrinos: global analysis and implications for SNO [PDF]

open access: yes, 2001
We present a global analysis of all the available solar neutrino data treating consistently the 8B and hep neutrino fluxes as free parameters. The analysis reveals at 99.7% C.L.
Bahcall, John N.   +2 more
core   +1 more source

Integrative transcriptomic analysis identifies emetine as a promising candidate for overcoming acquired resistance to ALK inhibitors in lung cancer

open access: yesMolecular Oncology, Volume 19, Issue 4, Page 1155-1169, April 2025.
We propose an efficient strategy to suppress ALK inhibitor (ALKi) resistance. By analyzing transcriptome data, we identified emetine as a potential inhibitor. We demonstrated that emetine exhibited effectiveness in inhibiting the growth of ALKi‐resistant cells, and further interpreted its impact on the resistant signatures through drug‐induced RNA ...
Sang‐Min Park   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy